Skip to main content
Back
Watch Compare

Vor Biopharma Inc.

Data quality: 83%
VOR
NASDAQ Manufacturing Chemicals
$15.47
▼ $0.13 (-0.83%)
Mkt Cap: 758.11 M
Price
$15.52
Mkt Cap
758.11 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -143.65 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-193.16%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio9.16
Interest CoverageN/A

Valuation

PE (TTM)
-1.09
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1366 peers)
Metric Stock Sector Median
P/E -1.1 -1.5
P/B — 1.6
ROE % — -53.6
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

8 analysts
Buy
Current
$15.47
+143.2%
Target
$37.63
$15.00
$40.00
$50.00
Forecast
Forward P/E -3.57
Forward EPS -$4.33
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$4.33
-$7.01 – -$3.22
 0.0 5
FY2026 -$3.16
-$3.42 – -$2.93
 0.0 3

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$1.19 $307.53 +25920.3%
Q32025 -$4.10 -$121.63 -2866.6%
Q22025 -$11.80 -$251.20 -2028.8%
Q12025 -$4.16 -$5.20 -25.0%

ETFs Holding This Stock

CNCR CNCR
1.88% weight
BRSIX BRSIX
0.08% weight
SHISX SHISX
0.01% weight
SHSCX SHSCX
0.01% weight
SHSAX SHSAX
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -695.98 M
ROE N/A ROA -364.76%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -143.65 M
ROIC -193.16% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 9.16
Interest Coverage N/A Asset Turnover N/A
Working Capital 153.65 M Tangible Book Value -2.23 B
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.09 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -18.95%
Market Cap 758.11 M Enterprise Value 597.65 M
Per Share
EPS (Diluted TTM) -70.50 Revenue / Share N/A
FCF / Share -2.94 OCF / Share -2.92
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 20.64%
SBC-Adj. FCF -157.72 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -695.98 M -116.91 M -117.86 M -92.09 M -68.90 M
EPS (Diluted) -70.50 -1.70 -1.75 -2.33 —
Gross Profit — — — — —
Operating Income -371.64 M -121.19 M -126.04 M -93.42 M -69.02 M
EBITDA — — — — —
R&D Expenses 321.53 M 93.31 M 94.32 M 64.55 M 47.53 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 464.13 M 142.89 M 198.13 M 299.37 M 242.59 M
Total Liabilities 628.44 M 46.23 M 47.40 M 48.76 M 26.33 M
Shareholders' Equity -164.31 M 96.66 M 150.72 M 250.61 M 216.26 M
Total Debt — — — — —
Cash & Equivalents 396.49 M 81.95 M 31.36 M 57.71 M 119.80 M
Current Assets 458.11 M 96.51 M 140.80 M 236.95 M 214.40 M
Current Liabilities 25.17 M 18.61 M 15.57 M 13.12 M 10.15 M